Hilton Worldwide Holdings Inc. · HLT · FY2026 Q2 · Calendar Q3 2026

Hilton raises RevPAR outlook as pipeline and owner initiatives advance

Hilton's Q2 analysis supports a constructive but conditional view: resilient U.S. business-transient demand, a record development pipeline, and higher RevPAR guidance strengthen the growth case, while China and Middle East exposure plus execution risk around owner profitability temper the outlook.

Reported Before market openNYSEConsumer Cyclical $69.14B market cap
100quality score

Earnings scorecard

Reported versus consensus
Reported EPS $2.29 Consensus $2.27
EPS surprise +0.9% Reported versus consensus
Reported revenue $3.34B Consensus $3.32B
Revenue surprise +0.5% Reported versus consensus

Market reaction

prior-close to event-session close
Stock move -2.5% Event window
SPY move +0.2% Same window
Abnormal move -2.8% Stock minus SPY
Volume 1.9× Versus trailing sessions
Subsequent drift +2.1% Up to 20 sessions
HLTSPY benchmark

Ask FN2 about HLT FY2026 Q2

Transcript, numbers and history already loaded

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Transcript intelligence

What changed

Compared with the prior-quarter analysis, Hilton reported stronger Q2 RevPAR growth, raised full-year RevPAR guidance, and expanded its development pipeline. The company also introduced the Undergraduate brand, added a Navan API integration, and emphasized Project RISE and loyalty fee reductions as new owner-profitability initiatives.

Guidance delta

Management raised full-year RevPAR guidance to 3–3.5% while maintaining a 6–7% net unit growth target.

Key takeaways

  • Q2 RevPAR growth and adjusted EBITDA exceeded the high end of guidance, according to the supplied transcript analysis.
  • The development pipeline reached a record 541,000 rooms, with more than 200 openings and 43,000 rooms signed during the quarter.
  • Project RISE and loyalty fee reductions are intended to improve owner profitability, with management analysis indicating a potential 75–100 basis-point margin benefit for owners.
  • Hilton highlighted U.S. business-transient demand, World Cup events, and new brand launches as demand and growth supports.
  • China weakness, Middle East exposure, and execution of profitability initiatives remain important variables.

Management priorities

  • Expand the development pipeline and achieve the 6–7% net unit growth target.
  • Launch and expand brands including Undergraduate, Conrad, Curio, and Home2 Suites in targeted markets.
  • Improve owner economics through Project RISE and loyalty fee reductions.
  • Continue investment in the AI Planner and technology platform, including the Navan API integration.
  • Support direct bookings and owner returns through technology and distribution initiatives.

Follow HLT with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Earnings History

Estimate Beat Miss Match
HLT EPS earnings history estimate and actual scatter chart 9 reported fiscal quarters and 3 future estimate-only quarters. Q1 '24 estimate $1.41 Q1 '24 actual $1.53, beat Q2 '24 estimate $1.86 Q2 '24 actual $1.91, beat Q3 '24 estimate $1.84 Q3 '24 actual $1.92, beat Q2 '25 estimate $2.05 Q2 '25 actual $2.20, beat Q3 '25 estimate $2.06 Q3 '25 actual $2.11, beat Q4 '25 estimate $2.02 Q4 '25 actual $2.08, beat Q1 '26 estimate $1.98 Q1 '26 actual $2.01, beat Q2 '26 estimate $2.27 Q2 '26 actual $2.29, beat Q3 '26 estimate $2.35 Q4 '26 estimate $2.28 Q1 '27 estimate $2.17
Show 1 more >

Analyst Consensus ?

ConsensusBuy49 ratings
Bullish2857.1%
Neutral2142.9%
Bearish00.0%

Analyst 52W Price Targets

$307.22Current
$135Low
$276.91Average
$379High

Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 24, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
Truist Securities Hold HoldMaintainSep 10, 2026
Susquehanna Neutral NeutralMaintainAug 11, 2026
Wells Fargo Overweight OverweightMaintainJul 30, 2026
Macquarie Neutral NeutralMaintainJul 29, 2026
Barclays Overweight OverweightMaintainJul 29, 2026
Baird Outperform OutperformMaintainJul 29, 2026
JP Morgan Overweight OverweightMaintainJul 21, 2026
Evercore ISI Group Outperform In LineUpgradeJul 21, 2026
Morgan Stanley Overweight OverweightMaintainJul 17, 2026
Bernstein Market Perform Market PerformMaintainMay 15, 2026
UBS Buy BuyMaintainApr 30, 2026
Mizuho Neutral NeutralMaintainApr 29, 2026
Goldman Sachs Buy NeutralUpgradeDec 15, 2025
Raymond James Outperform OutperformMaintainJul 30, 2025
B of A Securities Buy BuyMaintainJul 21, 2025
Jefferies Buy HoldUpgradeMay 12, 2025
TD Cowen Buy BuyMaintainOct 24, 2024
Melius Research Hold BuyDowngradeOct 21, 2024
Deutsche Bank Hold HoldMaintainAug 8, 2024
HSBC Buy BuyMaintainApr 3, 2024
BMO Capital Market Perform Market PerformMaintainMar 20, 2024
Citigroup Neutral BuyDowngradeDec 14, 2022
Redburn Partners Neutral NeutralMaintainNov 30, 2022
Berenberg Buy HoldUpgradeSep 15, 2022
Argus Research Buy BuyMaintainDec 28, 2021
Gordon Haskett Hold HoldMaintainJun 26, 2020
Nomura Instinet Buy BuyMaintainJun 23, 2020
Nomura Buy BuyMaintainJun 23, 2020
SunTrust Robinson Humphrey Hold HoldMaintainMay 8, 2020
RBC Capital Sector Perform OutperformDowngradeMar 30, 2020
Longbow Research Neutral BuyDowngradeJul 15, 2019
Argus Hold BuyDowngradeNov 5, 2018
B. Riley Securities Buy NeutralUpgradeOct 25, 2018
B. Riley FBR Buy NeutralUpgradeOct 25, 2018
Cowen & Co. Outperform OutperformMaintainOct 23, 2018
B. Riley Neutral NeutralMaintainApr 27, 2018
FBR Capital Neutral OutperformDowngradeOct 27, 2017
Tigress Financial Neutral NeutralMaintainApr 27, 2017
Guggenheim Neutral NeutralMaintainApr 26, 2017
Telsey Advisory Group Perform OutperformDowngradeApr 3, 2017
Bank of America Buy NeutralUpgradeDec 15, 2016
MKM Partners Buy SellUpgradeDec 5, 2016
JMP Securities Market Outperform Market OutperformMaintainJul 28, 2016
Wolfe Research Outperform OutperformMaintainJul 6, 2016
CLSA Buy BuyMaintainApr 12, 2016
Brean Capital Buy BuyMaintainJun 10, 2015
Credit Suisse Outperform OutperformMaintainNov 21, 2014
Craig-Hallum Buy HoldUpgradeMay 23, 2014
ISI Group Neutral NeutralMaintainJan 21, 2014
Show less

Named analyst price targets

Upside is calculated against the persisted current price $307.22. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
Truist FinancialPatrick Scholes$316$308.66 +2.9%Sep 10, 2026
UBSRobin Farley$363$324.99 +18.2%Aug 14, 2026
Deutsche BankAnalyst unavailable$365$314.66 +18.8%Aug 12, 2026
BarclaysAnalyst unavailable$368$322.43 +19.8%Jul 29, 2026
BarclaysBrandt Montour$367$321.32 +19.5%Jul 20, 2026
Wells FargoAnalyst unavailable$379$328.48 +23.4%Jul 16, 2026
BernsteinRichard Clarke$320$316.56 +4.2%May 15, 2026
Morgan StanleyAnalyst unavailable$319$315.92 +3.8%May 12, 2026
UBSAnalyst unavailable$371$323.98 +20.8%Apr 30, 2026
Truist FinancialAnalyst unavailable$312$315.74 +1.6%Apr 29, 2026
SusquehannaAnalyst unavailable$353$323.34 +14.9%Apr 29, 2026
BarclaysAnalyst unavailable$365$323.34 +18.8%Apr 29, 2026
Evercore ISIAnalyst unavailable$350$335.07 +13.9%Apr 24, 2026
SusquehannaAnalyst unavailable$345$333.67 +12.3%Apr 23, 2026
BarclaysAnalyst unavailable$363$328.91 +18.2%Apr 16, 2026
Morgan StanleyStephen Grambling$318$321.31 +3.5%Apr 10, 2026
UBSAnalyst unavailable$360$315.96 +17.2%Feb 22, 2026
Truist FinancialPatrick Scholes$307$326.1 -0.1%Feb 12, 2026
BarclaysAnalyst unavailable$350$332.91 +13.9%Feb 12, 2026
Mizuho SecuritiesAnalyst unavailable$321$325.13 +4.5%Feb 12, 2026
Wells FargoAnalyst unavailable$373$329.82 +21.4%Feb 12, 2026
JefferiesDavid Katz$339$326.55 +10.3%Feb 11, 2026
Evercore ISIAnalyst unavailable$325$296.46 +5.8%Jan 22, 2026
Morgan StanleyAnalyst unavailable$306$301.86 -0.4%Jan 16, 2026
BarclaysAnalyst unavailable$309$301.86 +0.6%Jan 16, 2026
BernsteinAnalyst unavailable$304$287.73 -1.0%Jan 6, 2026
Goldman SachsAnalyst unavailable$317$280.05 +3.2%Dec 15, 2025
Truist FinancialAnalyst unavailable$253$271.08 -17.6%Oct 23, 2025
Deutsche BankAnalyst unavailable$287$275.06 -6.6%Oct 23, 2025
SusquehannaAnalyst unavailable$255$275.06 -17.0%Oct 23, 2025
Goldman SachsLizzie Dove$285$275.06 -7.2%Oct 23, 2025
BarclaysBrandt Montour$297$271.99 -3.3%Oct 23, 2025
Morgan StanleyAnalyst unavailable$289$265.96 -5.9%Oct 22, 2025
Robert W. BairdAnalyst unavailable$275$258.23 -10.5%Oct 17, 2025
BarclaysAnalyst unavailable$288$258.91 -6.3%Oct 3, 2025
BernsteinAnalyst unavailable$288$266.41 -6.3%Sep 17, 2025
Raymond JamesAnalyst unavailable$300$273.29 -2.4%Jul 30, 2025
Morgan StanleyStephen Grambling$286$274.34 -6.9%Jul 15, 2025
Mizuho SecuritiesBen Chaiken$263$258.74 -14.4%Feb 5, 2025
Wells FargoDaniel Politzer$240$258.74 -21.9%Feb 4, 2025
Truist FinancialPatrick Scholes$220$233.5 -28.4%Oct 24, 2024
Deutsche BankCarlo Santarelli$200$233.5 -34.9%Oct 24, 2024
Evercore ISIDuane Pfennigwerth$240$238.81 -21.9%Oct 21, 2024
BarclaysBrandt Montour$244$238.47 -20.6%Oct 18, 2024
Robert W. BairdMichael Bellisario$235$237.49 -23.5%Oct 17, 2024
Goldman SachsLizzie Dove$245$220.38 -20.3%Sep 18, 2024
BernsteinRichard Clarke$261$217.08 -15.0%Aug 29, 2024
MacquarieChad Beynon$208$205.07 -32.3%Aug 7, 2024
BarclaysBrandt Montour$228$228.19 -25.8%Jul 17, 2024
Argus ResearchJohn Staszak$260$228.47 -15.4%Jul 16, 2024
Truist FinancialPatrick Scholes$209$203.57 -32.0%Apr 25, 2024
MacquarieChad Beynon$205$203.86 -33.3%Apr 25, 2024
Deutsche BankCarlo Santarelli$185$203.98 -39.8%Apr 25, 2024
Robert W. BairdMichael Bellisario$215$204.7 -30.0%Apr 25, 2024
BarclaysBrandt Montour$216$198.82 -29.7%Apr 19, 2024
HSBCMeredith Jensen$254$210.37 -17.3%Apr 3, 2024
Wells FargoJeffrey Donnelly$200$210.51 -34.9%Mar 20, 2024
Evercore ISIDiane Pfenningwerth$210$210.51 -31.6%Mar 20, 2024
Robert W. BairdMichael Bellisario$210$204.66 -31.6%Mar 15, 2024
BarclaysBrandt Montour$168$147.44 -45.3%Mar 9, 2023
Morgan StanleyAnalyst unavailable$167$145.82 -45.6%Feb 7, 2023
Wells FargoAnalyst unavailable$148$147.98 -51.8%Feb 2, 2023
BarclaysAnalyst unavailable$139$136.05 -54.8%Dec 15, 2022
CitigroupAnalyst unavailable$148$138.11 -51.8%Dec 14, 2022
Truist FinancialAnalyst unavailable$147$140.28 -52.2%Dec 5, 2022
Morgan StanleyAnalyst unavailable$171$141.42 -44.3%Dec 5, 2022
Truist FinancialAnalyst unavailable$62$140.65 -79.8%Nov 15, 2022
UBSAnalyst unavailable$159$129.83 -48.2%Aug 3, 2022
UBSRobin Farley$157$132.85 -48.9%May 17, 2022
Morgan StanleyAnalyst unavailable$144$145.38 -53.1%May 4, 2022
Morgan StanleyAnalyst unavailable$143$157.02 -53.5%May 2, 2022
Wells FargoDori Kesten$160$150.67 -47.9%Feb 26, 2022
MacquarieChad Beynon$138$150.41 -55.1%Feb 20, 2022
Morgan StanleyThomas Allen$135$143.39 -56.1%Jan 30, 2022
Evercore ISIRichard Hightower$155$144.52 -49.5%Jan 18, 2022
BernsteinRichard Clarke$161$148.61 -47.6%Jan 10, 2022
Argus ResearchJohn Staszak$178$155.02 -42.1%Dec 28, 2021
Loop Capital MarketsDaniel Adam$142$139.59 -53.8%Dec 2, 2021
Truist FinancialPatrick Scholes$139$146.04 -54.8%Oct 28, 2021
Show less

Track every rating change on HLT the moment it posts. Free to start.

Start free

Company context

Snapshot as of publication

Hilton Worldwide Holdings Inc., a hospitality company, engages in managing, franchising, and leasing hotels and resorts. It operates in two segments, Management and Franchise, and Ownership. The company engages in the hotel management and licensing of its brand names, trademarks, and service marks. It operates a brand portfolio of luxury, lifestyle, full service, focused service, all-suites hotel, and timeshare under the Waldorf Astoria Hotels & Resorts, LXR Hotels & Resorts, Conrad Hotels & Resorts, Signia by Hilton, NoMad, Canopy by Hilton, Graduate by Hilton, Tempo by Hilton, Motto by Hilton, Hilton Hotels & Resorts, DoubleTree…

Historical context

All HLT earnings

Consumer Cyclical peers this season

Latest reports in the same sector

Latest beats and misses

Who reports next

Get the HLT recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Sources

  1. Earnings call transcript and parsed analysis · 2026-07-28T15:06:53.127434+00:00
  2. FN2 earnings calendar · 2026-09-02T01:23:14.593608+00:00
  3. Polygon adjusted daily market bars · 2026-09-24T02:30:53.846951+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-24T02:30:53.844169+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated · As of 2026-09-24. For educational purposes only; not investment advice.